HIVES

Clinical trials for HIVES explained in plain language.

Never miss a new study

Get alerted when new HIVES trials appear

Sign up with your email to follow new studies for HIVES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New pill could tame stubborn hives when antihistamines fail

Disease control Completed

This phase 2 trial tested an oral drug called povorcitinib in 136 adults with chronic spontaneous urticaria (hives and itching lasting months) that standard antihistamines couldn't control. Participants took either povorcitinib or a placebo for 12 weeks to see if the drug reduced…

Matched conditions: HIVES

Phase: PHASE2 • Sponsor: Incyte Corporation • Aim: Disease control

Last updated Jun 27, 2026 11:00 UTC

HIVES

Get alerted when new HIVES trials appear

New pill could tame stubborn hives when antihistamines fail